1. Home
  2. CLDX vs SFL Comparison

CLDX vs SFL Comparison

Compare CLDX & SFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLDX
  • SFL
  • Stock Information
  • Founded
  • CLDX 1983
  • SFL 2003
  • Country
  • CLDX United States
  • SFL Bermuda
  • Employees
  • CLDX N/A
  • SFL N/A
  • Industry
  • CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • SFL Marine Transportation
  • Sector
  • CLDX Health Care
  • SFL Consumer Discretionary
  • Exchange
  • CLDX Nasdaq
  • SFL Nasdaq
  • Market Cap
  • CLDX 1.8B
  • SFL 1.7B
  • IPO Year
  • CLDX 2008
  • SFL N/A
  • Fundamental
  • Price
  • CLDX $25.77
  • SFL $9.99
  • Analyst Decision
  • CLDX Buy
  • SFL Strong Buy
  • Analyst Count
  • CLDX 8
  • SFL 2
  • Target Price
  • CLDX $64.83
  • SFL $14.50
  • AVG Volume (30 Days)
  • CLDX 992.8K
  • SFL 823.0K
  • Earning Date
  • CLDX 11-06-2024
  • SFL 02-12-2025
  • Dividend Yield
  • CLDX N/A
  • SFL 10.95%
  • EPS Growth
  • CLDX N/A
  • SFL 39.68
  • EPS
  • CLDX N/A
  • SFL 1.10
  • Revenue
  • CLDX $9,976,000.00
  • SFL $876,068,000.00
  • Revenue This Year
  • CLDX N/A
  • SFL $21.02
  • Revenue Next Year
  • CLDX N/A
  • SFL N/A
  • P/E Ratio
  • CLDX N/A
  • SFL $8.99
  • Revenue Growth
  • CLDX 128.55
  • SFL 19.50
  • 52 Week Low
  • CLDX $22.93
  • SFL $9.67
  • 52 Week High
  • CLDX $53.18
  • SFL $14.62
  • Technical
  • Relative Strength Index (RSI)
  • CLDX 45.64
  • SFL 35.59
  • Support Level
  • CLDX $24.48
  • SFL $9.67
  • Resistance Level
  • CLDX $26.66
  • SFL $10.68
  • Average True Range (ATR)
  • CLDX 1.19
  • SFL 0.21
  • MACD
  • CLDX 0.03
  • SFL -0.06
  • Stochastic Oscillator
  • CLDX 35.73
  • SFL 27.14

About CLDX Celldex Therapeutics Inc.

Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. Its pipeline products are Varlilumab, CDX-301, CDX-1140,CDX-0159/Anti-KIT Program, and CDX-527.

About SFL SFL Corporation Ltd

SFL Corp Ltd is an international ship owning and chartering company. The company is engaged primarily in the ownership and operation of vessels and offshore related assets and is also involved in the charter, purchase, and sale of assets. Its oil tankers, chemical tankers, and oil product tankers are all double-hull vessels.

Share on Social Networks: